Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 10/31/2018
Entire Document
 


In re: Orexigen Therapeutics, Inc.

Debtor

  

Case No. 18-10518 (KG)

Reporting Period: September 1, 2018 - September 30, 2018

 

MOR - 1a

Schedule of Disbursements by Debtor Entity (1)

For the Period: September 1, 2018 - September 30, 2018

(Unaudited)

 

$ USD ‘000s
Debtor

  September 1, 2018 - September 30, 2018     Cumulative
Since Filing
 

Orexigen Therapeutics, Inc.

  $ 3,694     $ 130,204  
 

 

 

   

 

 

 

Total

  $ 3,694     $ 130,204  

Notes:

 

(1)

The Schedule of Disbursements is presented on a book basis.